IS7159A - Ný imídasópýridínefnasambönd sem hafa meðferðarfræðileg áhrif - Google Patents
Ný imídasópýridínefnasambönd sem hafa meðferðarfræðileg áhrifInfo
- Publication number
- IS7159A IS7159A IS7159A IS7159A IS7159A IS 7159 A IS7159 A IS 7159A IS 7159 A IS7159 A IS 7159A IS 7159 A IS7159 A IS 7159A IS 7159 A IS7159 A IS 7159A
- Authority
- IS
- Iceland
- Prior art keywords
- therapeutic effects
- imidazopyridine compounds
- new imidazopyridine
- new
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102808A SE0102808D0 (sv) | 2001-08-22 | 2001-08-22 | New compounds |
| PCT/SE2002/001489 WO2003018582A1 (en) | 2001-08-22 | 2002-08-21 | Novel imidazopyridine compounds with therapeutic effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7159A true IS7159A (is) | 2004-02-20 |
Family
ID=20285105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7159A IS7159A (is) | 2001-08-22 | 2004-02-20 | Ný imídasópýridínefnasambönd sem hafa meðferðarfræðileg áhrif |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20040220209A1 (is) |
| EP (1) | EP1421083A1 (is) |
| JP (1) | JP2005501870A (is) |
| KR (1) | KR20040036723A (is) |
| CN (1) | CN100343252C (is) |
| AR (1) | AR035465A1 (is) |
| BR (1) | BR0211846A (is) |
| CA (1) | CA2456350A1 (is) |
| HU (1) | HUP0401350A3 (is) |
| IL (1) | IL160143A0 (is) |
| IS (1) | IS7159A (is) |
| MX (1) | MXPA04001402A (is) |
| NO (1) | NO20040760L (is) |
| NZ (1) | NZ531110A (is) |
| PL (1) | PL367971A1 (is) |
| RU (1) | RU2294935C2 (is) |
| SE (1) | SE0102808D0 (is) |
| WO (1) | WO2003018582A1 (is) |
| ZA (1) | ZA200401114B (is) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0301904D0 (sv) | 2003-06-26 | 2003-06-26 | Astrazeneca Ab | Novel imidazopyridine compound II with therapeutic effect |
| EP1974730A1 (en) | 2003-11-03 | 2008-10-01 | AstraZeneca AB | Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux |
| WO2005070927A2 (en) * | 2004-01-26 | 2005-08-04 | Altana Pharma Ag | 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors |
| EA011512B1 (ru) * | 2004-12-17 | 2009-04-28 | Ракуалиа Фарма Инк. | Производные хромана, полезные в качестве антагонистов кислотной помпы |
| GB0513423D0 (en) * | 2005-06-30 | 2005-08-03 | Glaxo Group Ltd | Novel compounds |
| KR20080108129A (ko) * | 2006-03-17 | 2008-12-11 | 라퀄리아 파마 인코포레이티드 | 크로메인 유도체 |
| WO2008059373A1 (en) * | 2006-11-17 | 2008-05-22 | Raqualia Pharma Inc. | Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists |
| KR200449743Y1 (ko) * | 2008-03-11 | 2010-08-05 | 주식회사 보루네오가구 | 파티션용 상부 스크린의 고정구조 |
| FI20086158A0 (fi) | 2008-12-03 | 2008-12-03 | Mikael Dahlstroem | Imidatsopyridiinijohdannaiset |
| JP5802898B2 (ja) | 2009-07-09 | 2015-11-04 | ラクオリア創薬株式会社 | 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤 |
| CN102548991B (zh) * | 2009-09-24 | 2015-03-25 | 霍夫曼-拉罗奇有限公司 | 作为磷酸二酯酶10a抑制剂的咪唑并吡啶或咪唑并嘧啶衍生物 |
| FR2962437B1 (fr) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique |
| CN105246888B (zh) * | 2013-01-31 | 2017-09-05 | 尼奥迈德研究所 | 咪唑并吡啶化合物及其用途 |
| CN105164126B (zh) * | 2013-04-30 | 2017-05-31 | 豪夫迈·罗氏有限公司 | 吡唑酰胺的Pd‑催化偶联 |
| CN106279151A (zh) * | 2015-06-26 | 2017-01-04 | 江苏太瑞生诺生物医药科技有限公司 | 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA81219B (en) * | 1980-01-23 | 1982-01-27 | Schering Corp | Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them |
| DE3269604D1 (en) * | 1981-06-26 | 1986-04-10 | Schering Corp | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
| US4725601A (en) * | 1985-06-04 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers |
| EP0228006A1 (en) * | 1985-12-16 | 1987-07-08 | Fujisawa Pharmaceutical Co., Ltd. | Imidazopyridine compounds and processes for preparation thereof |
| SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
| SE9802794D0 (sv) * | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
-
2001
- 2001-08-22 SE SE0102808A patent/SE0102808D0/xx unknown
-
2002
- 2002-08-09 AR ARP020103019A patent/AR035465A1/es not_active Application Discontinuation
- 2002-08-21 HU HU0401350A patent/HUP0401350A3/hu unknown
- 2002-08-21 CA CA002456350A patent/CA2456350A1/en not_active Abandoned
- 2002-08-21 KR KR10-2004-7002466A patent/KR20040036723A/ko not_active Application Discontinuation
- 2002-08-21 MX MXPA04001402A patent/MXPA04001402A/es unknown
- 2002-08-21 NZ NZ531110A patent/NZ531110A/en unknown
- 2002-08-21 WO PCT/SE2002/001489 patent/WO2003018582A1/en active IP Right Grant
- 2002-08-21 PL PL02367971A patent/PL367971A1/xx not_active Application Discontinuation
- 2002-08-21 US US10/487,149 patent/US20040220209A1/en not_active Abandoned
- 2002-08-21 JP JP2003523243A patent/JP2005501870A/ja active Pending
- 2002-08-21 EP EP02759036A patent/EP1421083A1/en not_active Withdrawn
- 2002-08-21 RU RU2004103628/04A patent/RU2294935C2/ru not_active IP Right Cessation
- 2002-08-21 IL IL16014302A patent/IL160143A0/xx unknown
- 2002-08-21 CN CNB028160177A patent/CN100343252C/zh not_active Expired - Fee Related
- 2002-08-21 BR BR0211846-7A patent/BR0211846A/pt not_active IP Right Cessation
-
2004
- 2004-02-11 ZA ZA200401114A patent/ZA200401114B/en unknown
- 2004-02-20 NO NO20040760A patent/NO20040760L/no not_active Application Discontinuation
- 2004-02-20 IS IS7159A patent/IS7159A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL160143A0 (en) | 2004-06-20 |
| US20040220209A1 (en) | 2004-11-04 |
| AR035465A1 (es) | 2004-05-26 |
| RU2294935C2 (ru) | 2007-03-10 |
| HUP0401350A3 (en) | 2009-03-02 |
| NZ531110A (en) | 2005-10-28 |
| JP2005501870A (ja) | 2005-01-20 |
| MXPA04001402A (es) | 2004-05-27 |
| SE0102808D0 (sv) | 2001-08-22 |
| PL367971A1 (en) | 2005-03-07 |
| WO2003018582A1 (en) | 2003-03-06 |
| KR20040036723A (ko) | 2004-04-30 |
| CA2456350A1 (en) | 2003-03-06 |
| CN1543464A (zh) | 2004-11-03 |
| BR0211846A (pt) | 2004-09-08 |
| ZA200401114B (en) | 2005-06-22 |
| CN100343252C (zh) | 2007-10-17 |
| HUP0401350A2 (hu) | 2004-12-28 |
| NO20040760L (no) | 2004-02-20 |
| RU2004103628A (ru) | 2005-06-27 |
| EP1421083A1 (en) | 2004-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7236A (is) | Meðferðarfræðileg ísókínólínefnasambönd | |
| NO20034176L (no) | Pyrazolopyrimidiner som terapeutiske midler | |
| NO20034177D0 (no) | Pyrazolopyrimidiner som terapeutiske midler | |
| MA27043A1 (fr) | Azaindoles | |
| NO20052914D0 (no) | Terapeutiske forbindelser | |
| IS6971A (is) | Ný efnasambönd | |
| NO20033203D0 (no) | Terapeutiske heterocykliske forbindelser | |
| NO20033205L (no) | Terapeutiske kromanforbindelser | |
| EE200200568A (et) | Ravis kasutatavad difenüüleetriühendid | |
| IS7159A (is) | Ný imídasópýridínefnasambönd sem hafa meðferðarfræðileg áhrif | |
| GB0108930D0 (en) | Therapeutic agents | |
| GB0108982D0 (en) | Therapeutic agents | |
| DE10157913B4 (de) | Therapietisch | |
| SE0100006D0 (sv) | Therapeutic compounds | |
| SE0100009D0 (sv) | Therapeutic compounds | |
| SE0100008D0 (sv) | Therapeutic compounds | |
| SE0100007D0 (sv) | Therapeutic compounds | |
| GB0108973D0 (en) | Therapeutic agents | |
| SE0004826D0 (sv) | Therapeutic compounds | |
| SE0004825D0 (sv) | Therapeutic compounds | |
| SE0003368D0 (sv) | Therapeutic compounds | |
| SE0103855D0 (sv) | Therapeutic agents | |
| SE0103854D0 (sv) | Therapeutic agents | |
| GB0100599D0 (en) | Therapeutic compounds | |
| GB0101636D0 (en) | Therapeutic compounds |